Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Medical Technology
  • Roche, Eli Lilly net FDA approval for first-of-its-kind Alzheimer’s biomarker blood test

Roche, Eli Lilly net FDA approval for first-of-its-kind Alzheimer’s biomarker blood test

August 24, 2026Posted inMedical Technology

Roche and Eli Lilly have won FDA clearance for their latest Alzheimer’s disease diagnostic.

Post navigation

Previous Post
triglyceride-glucose-index-linked-to-elevated-blood-pressure-in-us.-teens Triglyceride-Glucose Index Linked to Elevated Blood Pressure in U.S. Teens
Next Post
How Chromosomes Find Their Matching Partners how-chromosomes-find-their-matching-partners

Recent Posts

  • Goal-Oriented Nutritional Model Incorporates Multiple Modes and Dietary Transitions
  • Study finds racial, ethnic, and income gaps in California EV charger access
  • Short-chain fatty acids mitigate cisplatin-induced sensory damage and hearing loss via MUTYH
  • Scientists develop radioafterglow nanoprobes to image hydrogen peroxide deep inside tissues
  • Roadmap Advances End-to-End, Task-Agnostic Exoskeleton Control

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top